Introduction: Pituitary neuroendocrine tumor (PitNET) may present multisecreting forms. Identifying its forms helps to guide management. This management is a real challenge, given the limited resources in our regions. In view of advances in the management of these multisecreting pituitary neuroendocrine tumors and the lack of published data in Africa, and in Senegal particularly, this survey was carried out with the aim of describing the epidemiological, clinical and therapeutic aspects of multisecreting PitNETs. Patients and Method: It was a multicenter, retrospective, descriptive and analytical study carried out on files collected from 1st January 2008 to 31 December 2022 in the neurosurgery departments of the Fann and Principal hospitals in Dakar and the endocrinology department of the Abass Ndao hospital in Dakar. Results: Of the 242 patients treated for PitNET, 09 presented (the mean age of our patients was 41.7 ± 11 years) with bihormonal PitNET, i.e. a proportion of 3.71%. Two types of association were found: 08 tumors with GH (Growth Hormon) + PRL (prolactin) secretion and 01 PitNET with ACTH (Adreno Corticotropic Homon) + prolactin secretion. Clinically, gonadotropic insufficiency was found in all patients (100%). Dysmorphic syndrome was found in 6 patients (66.7%) and tumor syndrome in 7 patients (77.8%). Ophthalmological evaluation revealed a decrease in visual acuity in 66.6% of patients. All had macroadenomas, with extension noted in 02 patients. All patients underwent transsphenoidal surgery with complications such as transient diabetes insipidus (3 patients, 33.3%), followed by cerebrospinal fluid leaks (1 patient, 11.1%). Remission was noted in all 5 patients tested. A comparison between the different secretory forms did not reveal any significant difference in the frequency of postoperative complications. Conclusion: Despite the lack of immunohistochemistry, two types of association were found: ACTH-PRL and GH-PRL. All were macroadenomas, the majority with an associated tumor syndrome. The latter was significantly less frequent in bisecreting PitNETs compared with monosecreting and non-functional forms. However, there was no significant difference in the occurrence of post-operative complications between the three secretory forms of PitNETs.
References
[1]
Asa, S.L., Casar-Borota, O., Chanson, P., Delgrange, E., Earls, P., Ezzat, S., et al. (2017) From Pituitary Adenoma to Pituitary Neuroendocrine Tumor (PitNET): An International Pituitary Pathology Club Proposal. Endocrine-Related Cancer, 24, C5-C8. https://doi.org/10.1530/erc-17-0004
[2]
Scheithauer, B.W., Horvath, E., Kovacs, K., Laws, E.R., Randall, R.V. and Ryan, N. (1986) Plurihormonal Pituitary Adenomas. Seminars in Diagnostic Pathology, 3, 69-82.
[3]
Kameya, T. and Furuhata, S. (1991) Plurihormonal Adenomas. Pathology—Research and Practice, 187, 574-576. https://doi.org/10.1016/s0344-0338(11)80147-0
[4]
McComb, D.J., Bayley, T.A., Horvath, E., Kovacs, K. and Kourides, I.A. (1984) Monomorphous Plurihormonal Adenoma of the Human Pituitary. A Histologic, Immunocytologic and Ultrastructural Study. Cancer, 53, 1538-1544. https://doi.org/10.1002/1097-0142(19840401)53:7<1538::aid-cncr2820530720>3.0.co;2-i
[5]
Budan, R.M. and Georgescu, C.E. (2016) Multiple Pituitary Adenomas: A Systematic Review. Frontiers in Endocrinology, 7, Article 1. https://doi.org/10.3389/fendo.2016.00001
[6]
Kontogeorgos, G., Kovacs, K., Horvath, E. and Scheithauer, B.W. (1991) Multiple Adenomas of the Human Pituitary. Journal of Neurosurgery, 74, 243-247. https://doi.org/10.3171/jns.1991.74.2.0243
[7]
Zieliński, G., Sajjad, E.A., Maksymowicz, M., Pękul, M. and Koziarski, A. (2019) Double Pituitary Adenomas in a Large Surgical Series. Pituitary, 22, 620-632. https://doi.org/10.1007/s11102-019-00996-2
[8]
Mete, O., Alshaikh, O.M., Cintosun, A., Ezzat, S. and Asa, S.L. (2018) Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages. Endocrine Pathology, 29, 332-338. https://doi.org/10.1007/s12022-018-9545-4
[9]
Raappana, A., Koivukangas, J., Ebeling, T. and Pirilä, T. (2010) Incidence of Pituitary Adenomas in Northern Finland in 1992–2007. The Journal of Clinical Endocrinology & Metabolism, 95, 4268-4275. https://doi.org/10.1210/jc.2010-0537
[10]
Kovacs, K., Horvath, E., Van loon, G.R., Rewcastle, N.B., Ezrin, C. and Rosenbloom, A.A. (1978) Pituitary Adenomas Associated with Elevated Blood Follicle-Stimulating Hormone Levels: A Histologic, Immunocytologic, and Electron Microscopic Study of Two Cases. Fertility and Sterility, 29, 622-628. https://doi.org/10.1016/s0015-0282(16)43333-9
[11]
Nishioka, H., Inoshita, N., Mete, O., Asa, S.L., Hayashi, K., Takeshita, A., et al. (2015) The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas. Endocrine Pathology, 26, 349-355. https://doi.org/10.1007/s12022-015-9398-z
[12]
Patronas, N., Bulakbasi, N., Stratakis, C.A., Lafferty, A., Oldfield, E.H., Doppman, J., et al. (2003) Spoiled Gradient Recalled Acquisition in the Steady State Technique Is Superior to Conventional Postcontrast Spin Echo Technique for Magnetic Resonance Imaging Detection of Adrenocorticotropin-Secreting Pituitary Tumors. The Journal of Clinical Endocrinology & Metabolism, 88, 1565-1569. https://doi.org/10.1210/jc.2002-021438
[13]
Ikeda, H. (2013) Demonstration of Improved Surgical Outcome in Patients with Both ACTH and GH Secreting Adenomas Diagnosed by a New Sensitive Method of MET-PET Fusion 3T-MRI.
[14]
Langlois, F., Lim, D.S.T., Varlamov, E., Yedinak, C.G., Cetas, J.S., McCartney, S., et al. (2017) Clinical Profile of Silent Growth Hormone Pituitary Adenomas; Higher Recurrence Rate Compared to Silent Gonadotroph Pituitary Tumors, a Large Single Center Experience. Endocrine, 58, 528-534. https://doi.org/10.1007/s12020-017-1447-6
[15]
Petry, C., Poli, J.H.Z., De Azevedo Dossin, I., et al. (2019) Evaluation of the Potential of the Ki67 Index to Predict Tumor Evolution in Patients with Pituitary Adenoma. International Journal of Clinical and Experimental Pathology, 12, 320-326.
[16]
Kontogeorgos, G., Scheithauer, B.W., Horvath, E., Kovacs, K., Lloyd, R.V., Smyth, H.S., et al. (1992) Double Adenomas of the Pituitary. Neurosurgery, 31, 840-849. https://doi.org/10.1097/00006123-199211000-00003
[17]
Magri, F., Villa, C., Locatelli, D., Scagnelli, P., Lagonigro, M.S., Morbini, P., et al. (2010) Prevalence of Double Pituitary Adenomas in a Surgical Series: Clinical, Histological and Genetic Features. Journal of Endocrinological Investigation, 33, 325-331. https://doi.org/10.1007/bf03346594
[18]
Burrow, G.N., Wortzman, G., Rewcastle, N.B., Holgate, R.C. and Kovacs, K. (1981) Microadenomas of the Pituitary and Abnormal Sellar Tomograms in an Unselected Autopsy Series. New England Journal of Medicine, 304, 156-158. https://doi.org/10.1056/nejm198101153040306
[19]
Ho, D.M., Hsu, C., Ting, L. and Chiang, H. (2001) Plurihormonal Pituitary Adenomas: Immunostaining of All Pituitary Hormones Is Mandatory for Correct Classification. Histopathology, 39, 310-319. https://doi.org/10.1046/j.1365-2559.2001.01204.x
[20]
Schöning, J.v., Flitsch, J., Lüdecke, D.K., Fahlbusch, R., Buchfelder, M., Buslei, R., et al. (2022) Multiple Tumorous Lesions of the Pituitary Gland. Hormones, 21, 653-663. https://doi.org/10.1007/s42000-022-00392-9
[21]
Ogando-Rivas, E., Alalade, A.F., Boatey, J. and Schwartz, T.H. (2017) Double Pituitary Adenomas Are Most Commonly Associated with GH and Acth-Secreting Tumors: Systematic Review of the Literature. Pituitary, 20, 702-708. https://doi.org/10.1007/s11102-017-0826-6
[22]
Melmed, S., Casanueva, F.F., Hoffman, A.R., Kleinberg, D.L., Montori, V.M., Schlechte, J.A., et al. (2011) Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 96, 273-288. https://doi.org/10.1210/jc.2010-1692
[23]
Selek, A., Cetinarslan, B., Canturk, Z., Tarkun, I., Hanazay, Y., Vural, C., et al. (2019) The Effect of Somatostatin Analogues on Ki-67 Levels in GH-Secreting Adenomas. Growth Hormone & IGF Research, 45, 1-5. https://doi.org/10.1016/j.ghir.2019.01.001
[24]
Kim, K., Yamada, S., Usui, M. and Sano, T. (2004) Preoperative Identification of Clearly Separated Double Pituitary Adenomas. Clinical Endocrinology, 61, 26-30. https://doi.org/10.1111/j.1365-2265.2004.02055.x
[25]
Vitaz, T.W., Inkabi, K.E. and Carrubba, C.J. (2011) Intraoperative MRI for Transphenoidal Procedures: Short-Term Outcome for 100 Consecutive Cases. Clinical Neurology and Neurosurgery, 113, 731-735. https://doi.org/10.1016/j.clineuro.2011.07.025
